AUSSCHEIDUNG HÄMHALTIGER POLYPEPTIDE
European patent · EP3722431 · In force
Register entry
- Publication number
- EP3722431
- Application number
- EP20157598
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 11, 2014
- Published
- Oct 14, 2020
- Granted
- Jun 10, 2026
- Protection ends at the latest
- Sep 10, 2034
- Next annual fee due
- Sep 30, 2026
- IPC classes
- C12N 15/82 (2006.01)C07K 14/805 (2006.01)
- Priority
- US 201361876676 P 11.09.2013US 201361908689 P 25.11.2013
- Divided from
- EP14844701
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 20, 2026
Agent’s address changed
- Representative
- Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich
Published in Swissreg on 20.10.2026
- Jun 10, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 10.06.2026
- Jun 10, 2026
Agent entered
- Representative
- Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich
Published in Swissreg on 10.06.2026
Parties
Inventor
FRASER, Rachel
San Francisco, CA California 94110, US
DAVIS, Simon Christopher
San Francisco, CA California 94110, US
BROWN, Patrick O'Reilly
Stanford, CA California 94305, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.